Task: Answer the MCQ question.
Question: Which drug exhibits a -17.354% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CC(=O)Nc1ccc(NC(=O)CN(c2ccc(C(C)C)cc2)S(=O)(=O)c2ccccc2)cc1
[b] Cc1ccc2nc(NC(=O)CN3CCOCC3)sc2c1
Answer: b. Cc1ccc2nc(NC(=O)CN3CCOCC3)sc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2nc(NC(=O)CN3CCOCC3)sc2c1
Cc1ccc2nc(NC(=O)CN3CCOCC3)sc2c1
N-(6-methyl-1,3-benzothiazol-2-yl)-2-morpholin-4-ylacetamide